NCLT secured creditors approve AEHL-AHCL amalgamation scheme

Nclt Scheme FiledStrategic Transactions View source PDF Explain this filing

DRAGARWQ · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.5%Reaction day

₹5035.00

prior close

₹5035.50

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.3%-0.1% vs market

Hospital peers, median of 23sector+0.4%-0.9% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and 0.9 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.7

10m

+2.5

15m

+1.3

30m

+1.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.5-0.3-0.1+0.4-0.9

Next day

-0.7-0.1-0.6+0.3-1.0

-0.7-0.8+0.1-0.4-0.3

-2.3-2.8+0.5-2.9+0.6

-0.3-1.0+0.7-0.6+0.3

-3.4+0.4-3.8-0.1-3.3

-0.2-0.5+0.3-1.6+1.4

15d

-0.3-1.9+1.6-2.0+1.7

+0.3+0.4-0.2-1.9+2.1

+6.4+3.5+2.9-1.2+7.6

+4.3+2.0+2.3-9.4+13.6

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 23Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The NCLT-convened meeting of secured creditors of Dr. Agarwal's Eye Hospital was held on July 2, 2026 in Chennai. Secured creditors approved the scheme of amalgamation with Dr. Agarwal's Health Care Limited, with 100 percent votes in favor from one creditor representing about INR 85.77 crore. This is one step in the NCLT process; further approvals from NCLT and other authorities are still needed before the scheme becomes effective.

Likely market impact

Positive step toward internal group restructuring; scheme still needs final NCLT and other regulatory approvals before becoming effective.